Lung Cancer

EDU 29 - (INTERACTIVE) Challenging Cases in Lung Cancer: NSCLC

9/18/2019

1:15 PM - 2:30 PM

Location: Room W196

Session Type: Education

1.25 AMA PRA Category 1 Credits™

1.25 CAMPEP Credits

1.50 MDCB Credits

Chair(s)

Kenneth Rosenzweig, MD, FASTRO

Icahn School of Medicine at Mount Sinai

This interactive session will focus on challenging non-small cell lung cancer cases that will be reviewed by a multidisciplinary expert panel. Controversial issues regarding treatment options for early stage or locally-advanced disease, radiation dose, radiation technique, integration with chemotherapy and targeted therapies will be analyzed. Relevant clinical trials will be discussed, as well as the role of surgery in selected cases.

Learning Objectives:

Discuss the management of non-small cell lung cancer.
Discuss controversial issues regarding treatment options for early stage disease, radiation dose, or radiation technique.
Incorporate immunotherapy into the treatment regiment of locally-advanced NSCLC patients.

Presentations:

1:15 PM - 1:30 PM
Introduction
Speaker: Kenneth Rosenzweig, MD, FASTRO – Icahn School of Medicine at Mount Sinai
1:30 PM - 1:45 PM
Chemotherapy/Immunotherapy/Targeted Therapy in the Treatment of NSCLC
Speaker: Martin Edelman, MD – Fox Chase Cancer Center
1:45 PM - 2:00 PM
Radiotherapeutic Management of NSCLC
Speaker: George Rodrigues, MD, PhD, FASTRO – London Health Sciences Centre
2:00 PM - 2:15 PM
Surgical Management of NSCLC
Speaker: Jessica Donington, MD – University of Chicago
2:15 PM - 2:30 PM
Audience Q&A
Speaker: Kenneth Rosenzweig, MD, FASTRO – Icahn School of Medicine at Mount Sinai

Kenneth Rosenzweig, MD, FASTRO

Icahn School of Medicine at Mount Sinai

Disclosure:
Employment
Mount Sinai Medical Center: Professor and Chairman: Employee

Biography:
Dr. Kenneth Rosenzweig is Professor and Chair of the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai in New York. Previously, he spent 13 years at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of thoracic malignancies with radiation therapy.
The focus of his work has been on incorporating new technology into radiation therapy treatment for these diseases. He has specifically worked on implementing and evaluating novel techniques such as intensity modulated radiation therapy, stereotactic body radiotherapy, deep inspiration breath hold, gated radiation therapy and the incorporation of PET scans into the radiation therapy treatment planning process. He was also the principal investigator of a dose escalation study that established the maximum tolerated dose of radiation therapy that can be safely delivered with radiation therapy. He has published over 150 articles in scientific journals on his work and has authored numerous textbook chapters. He has presented his research at numerous national and international scientific meetings.

Dr. Rosenzweig has served on many committees including the Radiation Therapy Oncology Group (RTOG) Lung Committee, the RTOG Data Monitoring Committee, the National Cancer Institute Clinical Trials Evaluation Panel and for many years he led the American College of Radiology’s Appropriateness Criteria Panel on Lung Cancer. He is a past President of the American Radium Society, the nation’s oldest medical society devoted to the study of cancer. He has also served as a Consultant to the International Atomic Energy Association. He is currently Vice Chair of the Radiation Oncology Review Committee of the American College of Graduate Medical Education. He is an annual ABR oral board examiner and develops written questions for the lung/sarcoma section. He attended Yale University School of Medicine and did his residency at the Joint Center for Radiation Therapy at Harvard Medical School.

Presentation(s):

Introduction
Wednesday, September 18
1:15 PM – 1:30 PM
EDU 29 - (INTERACTIVE) Challenging Cases in Lung Cancer: NSCLC
Wednesday, September 18
1:15 PM – 2:30 PM
Audience Q&A
Wednesday, September 18
2:15 PM – 2:30 PM

Send Email for Kenneth Rosenzweig

To

Subject

Body

<h1>  shared a speaker with you!</h1><div><b>Name:</b> Kenneth Rosenzweig</div><div><b>Organization:</b> Icahn School of Medicine at Mount Sinai</div><div><b>Position:</b> Not Available</div><div><b>Bio:</b> Dr. Kenneth Rosenzweig is Professor and Chair of the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai in New York. Previously, he spent 13 years at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of thoracic malignancies with radiation therapy. 
The focus of his work has been on incorporating new technology into radiation therapy treatment for these diseases. He has specifically worked on implementing and evaluating novel techniques such as intensity modulated radiation therapy, stereotactic body radiotherapy, deep inspiration breath hold, gated radiation therapy and the incorporation of PET scans into the radiation therapy treatment planning process. He was also the principal investigator of a dose escalation study that established the maximum tolerated dose of radiation therapy that can be safely delivered with radiation therapy. He has published over 150 articles in scientific journals on his work and has authored numerous textbook chapters. He has presented his research at numerous national and international scientific meetings.

Dr. Rosenzweig has served on many committees including the Radiation Therapy Oncology Group (RTOG) Lung Committee, the RTOG Data Monitoring Committee, the National Cancer Institute Clinical Trials Evaluation Panel and for many years he led the American College of Radiology’s Appropriateness Criteria Panel on Lung Cancer. He is a past President of the American Radium Society, the nation’s oldest medical society devoted to the study of cancer. He has also served as a Consultant to the International Atomic Energy Association. He is currently Vice Chair of the Radiation Oncology Review Committee of the American College of Graduate Medical Education. He is an annual ABR oral board examiner and develops written questions for the lung/sarcoma section. He attended Yale University School of Medicine and did his residency at the Joint Center for Radiation Therapy at Harvard Medical School.
</div>

Attendees who have favorited this

Nasser Al-Dhaibani
King Abdullah Medical City
Sarah Anderson
DNP, AGACNP-BC
Rush University Medical Center
Sarit Appel
MD
Chaim Sheba Medical Center
David Asher
University Of Miami
David Beyer
Medical Director
Northern Arizona Healthcare
Matthew Carpenter
Radiation Oncologist
Central Illinois Radiation Oncology Physicians
Michael Dritto
Dosimetrist
Intermountain Medical Center
Sarah Grabowski
Mercy Medical Center
Cesare Guida
OSPEDALE DEL MARE
Salvador Gutierrez Torres
MD
Instituto Nacional De Cancerologia
Donielle Johnson
Medical Dosimetrist
Norman Regional Health System
Michael Milano
University of Rochester
Eteri Natelauri
MD / Radiation Oncologist
Evex Medical Corporation
Henry Park
Assistant Professor
Yale University School Of Medicine
Hayley Peralta
Registered Nurse
Northwestern Memorial Hospital
Hina Saeed
Assistant Professor
Medical College Of Wisconsin
Gabriele Simontacchi
Dr.
AOU Careggi
Brent Stebleton
Medical Dosimetrist
Sanford Health
Rafal Suwinski
Prof.
Center Of Oncology Gliwice
Xiaoxue Xie
Hunan Cancer Hospital

EDU 29 - (INTERACTIVE) Challenging Cases in Lung Cancer: NSCLC

Chair(s)

Learning Objectives:

Presentations:

Kenneth Rosenzweig, MD, FASTRO

Presentation(s):

Send Email for Kenneth Rosenzweig

Assets

EDU 29 - (INTERACTIVE) Challenging Cases in Lung Cancer: NSCLC

Attendees who have favorited this

Please enter your access key

Send Email for EDU 29 - (INTERACTIVE) Challenging Cases in Lung Cancer: NSCLC